home > ict

International Clinical Trials

International Clinical Trials (ICT) is a specialist journal designed to provide global coverage of key topics pertinent to the clinical trials sector.

Published quarterly, and edited by Dr Graham Hughes, the journal offers a platform of communication and information-sharing for executive and strategic decision-makers, seeking out new trends and marketing opportunities, as well as putting a spotlight on the latest innovations coming to market. ICT is specifically designed to be of interest to those actively seeking to source services for improved efficiency in what is an increasingly competitive market.

Prompted by the synergies between trial operations and wider contract research and outsourcing issues, ICT joined forces with sister title European Pharmaceutical Contractor (EPC) in late-2015, in a move that brings added value to both brands. With EPC now an inserted edition within ICT, industry practitioners across these complementary subject areas now have unrivalled access to a wealth of shared views and analyses.
For further information please contact:

Nick Matthews   

Rupert Gilbey

Connect with us on Twitter: follow @IntClinTrials

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.

Featured in this issue
Ethics & Risk Management
End Point

Choice Words

Health literacy is closely tied to informed consent for trials but, comments Graham Hughes, ensuring patients have enough information to enrol and be treated is far from straightforward.
Late-Phase Studies

Post Haste

Taking a new drug beyond the highly controlled environment of a clinical trial, post-authorisation safety studies can provide ongoing safety information from real-world use. Jess Sohal at United BioSource Corporation has some tips on effective operational delivery.
Comment from the Editor

From regulatory compliance to quality management, this edition of ICT offers a wealth of practical advice on the conduct and planning of early- and late-phase trials. Graham Hughes provides an introduction.

Edited by
Dr Graham Hughes
Consultant in

Published quarterly in
February, May,
August and November
Banner of Clinical Innovation 2016.ICT on Samedan

Banner of Medical Device Trials 2016.ICT on Samedan
Industry Events

DIA 28th Annual EuroMeeting

6-8 April 2016, CCH Hamburg, Germany

The DIA 28th Annual EuroMeeting brings stakeholders together to collaborate on when, where and how innovation leads to advances in health care product development.
More info >>

News and Press Releases

New Video on ADCC Assays from BioOutsource Rapidly reveals the factors to consider when using ADCC assays for producing precise biosimilar comparability data

Sartorius Stedim Biotech (SSB) BioOutsource have announced a new video is now available on-line explaining how to overcome the issues associated with using antibody-dependent cell-mediated cytotoxicity (ADCC) assays.
More info >>

air transport logo


White Papers

ConsulTech GmbH

ConsulTech GmbH

ConsulTech is a consulting company founded in 1992. Since then, we have been supporting biotech-nology, pharmaceutical and medical technology companies as well as research institutions with the entire process of setting-up and executing proposals for R&D projects. In projects funded by the European Commission, ConsulTech supports the coordinator by resuming administrative tasks allow-ing coordinators and partners to fully concentrate on the scientific and technical success of the pro-ject. We solve financial and administrative issues, organise meetings, take care of the timely delivery of milestones and reports and much more.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement